Products

What will AGI do for Acrivastine?

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A20F9XAI7W, chemically known as 2-propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (e,e)- but generally known as acrivastine, which bears US NIH Compound Identifier 5284514. European Medicines Agency schedules Acrivastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05252MIG. The term ACRIVASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules acrivastine in its Anatomical Therapeutic Chemical (ATC) Classification. ACRIVASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acrivastine under HS 29333999 and SITC 51574. As of Q4 2014, ACRIVASTINE remains the US FDA Preferred Term for this commodity. Acrivastine bears US NLM identifiers UMLS ID C0054340 and NCI Concept Code C47383. SMILES: OC(=O)/C=C/C1NC(C(=C\CN2CCCC2)\C2CCC(CC2)C)CCC1.